Patent application number | Description | Published |
20090188272 | AUTOMATED STORAGE AND RETRIEVAL SYSTEM FOR STORING BIOLOGICAL OR CHEMICAL SAMPLES AT ULTRA-LOW TEMPERATURES - An automated storage and retrieval system stores containers, typically containing biological or chemical samples, at ultra-low temperatures, i.e., from about −50° C. to about −90° C., preferably about −80° C. under normal operating conditions. Dry gas air flows are used to reduce moisture and the consequential frost within the freezer compartment. A custom insulated door is provided with an access module and a tube picking compartment as well as servo motors for controlling a robot within the ultra-low temperature freezer compartment. The robot automatically places sample storage containers in stationary storage racks within the freezer compartment. Magnetic couplings are used to transmit mechanical power from outside of the freezer compartment to the robot inside of the freezer compartment. The robot has a simplified mechanical configuration. The custom door can be readily attached to standard freezer bodies. | 07-30-2009 |
20100028214 | TUBE PICKING MECHANISM FOR AN AUTOMATED, ULTRA-LOW TEMPERATURE STORAGE AND RETRIEVAL SYSTEM - A tube picking mechanism is designed for use in an automated, ultra-low temperature (e.g., −80° C.) storage and retrieval systems which stores biological or chemical samples. The samples are contained in storage tubes held in SBS footprint storage racks that are loaded into trays located within an ultra-low temperature freezer compartment (−80° C.). A tube picking mechanism resides in a tube picking chamber that is located adjacent the freezer compartment. The tube picking chamber is maintained at about −20° C. when the tube picking mechanism is in operation. The tube picking mechanism includes a cache within the tube picking chamber to facilitate fast paced shuttling of the tube racks from the freezer compartment into the tube picking chamber. The shuttle has a clamping mechanism to secure a tube rack in place when a gripper head picks a tube from the rack. The system also includes a push pin that pushes on the bottom of the respective tube as it is being picked from the tube rack. A one-dimensional bar code reader is included within the tube picking chamber. The gripper head is able to move vertically and rotate within the field of view of the one-dimensional bar code reader in order to facilitate identification and reading of one-dimensional bar codes located on the sidewall of picked storage tubes. The system also uses fans to facilitate efficient cooling of the tube picking chamber. | 02-04-2010 |
20110088424 | Automated Storage and Retrieval System for Storing Biological or Chemical Samples at Ultra-Low Temperatures - An automated storage and retrieval system stores containers, typically containing biological or chemical samples, at ultra-low temperatures, i.e., from about −50° C. to about −90° C., preferably about −80° C. under normal operating conditions. A robot automatically places sample storage containers in stationary storage racks within the freezer compartment. Magnetic couplings are used to transmit mechanical power from outside of the freezer compartment to the robot inside of the freezer compartment. The robot has a simplified mechanical configuration. | 04-21-2011 |
20120060514 | Tube Picking Mechanisms with an Ultra-Low Temperature or Cryogenic Picking Compartment - A tube picking mechanism is designed for use in an automated, ultra-low temperature (e.g. −80° C. or −135° C.) or cryogenic (e.g., about −140° C. to −196° C.) storage and retrieval system that stores biological or chemical samples. The samples are contained in storage tubes held in SBS footprint storage racks that are normally stored within an ultra-low temperature or cryogenic freezer compartment. The tube picking mechanism includes a tube picking chamber that is maintained at about −80° C., about −135° C. or at cryogenic temperatures in cryogenic applications. Active electrical and mechanical components are maintained in a compartment above and separate from the refrigerated, ultra-low temperature or cryogenic compartment. Thermal stratification inhibits heat transfer into the lower, ultra-low temperature or cryogenic compartment in which tube picking occurs from the upper compartment in which active electrical and mechanical components are located, and also inhibits heat transfer into the lower, ultra-low temperature or cryogenic compartment via an access door for tube storage racks. | 03-15-2012 |
Patent application number | Description | Published |
20090298081 | METHODS OF TREATMENT UTILIZING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR - The present invention provides binding proteins and antigen-binding fragments thereof, including human antibodies, that specifically bind to the human interleukin-21 receptor (IL-21R), and methods of using them. The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing, treating, and/or preventing IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, and other immune system disorders. | 12-03-2009 |
20100015162 | Methods of Using Antibodies Against Human IL-22 - The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22) and methods of using those antibodies, for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders. | 01-21-2010 |
20100075329 | METHODS FOR PREDICTING PRODUCTION OF ACTIVATING SIGNALS BY CROSS-LINKED BINDING PROTEINS - The present invention provides human binding proteins and antigen-binding fragments thereof that specifically bind to the human interleukin-21 receptor (IL21R), and uses therefore. The invention further provides methods to predict whether the binding proteins of the invention may take on agonistic activities in vivo and produce a cytokine storm. In addition, the invention provides methods for determining whether an anti-IL21R binding protein is a neutralizing anti-IL21R binding protein, based on the identification of several IL21-responsive genes. The binding proteins can act as, e.g., antagonists of IL21R activity, thereby modulating immune responses in general, and those mediated by IL21R in particular. | 03-25-2010 |
20110091478 | METHODS OF USING ANTIBODIES AGAINST HUMAN IL-22 - The present application provides human antibodies and antigen binding fragments thereof that specifically bind to the human interleukin-22 (IL-22) and methods of using those antibodies, for example, in diagnosing, treating or preventing inflammatory disorders, autoimmune diseases, allergies, septic shock, infectious disorders, transplant rejection, cancer, and other immune system disorders. | 04-21-2011 |
20110212099 | METHODS OF MODULATING IL-22 AND IL-17 - The present application provides methods of modulating immune responses by using IL-22 in combination with at least one of IL-17A, IL-17F, or IL-23 or by using an IL-22 antagonist, such as an antibody or a soluble receptor or a binding protein, in combination with an antagonist of at least one of IL-17A, IL-17F, or IL-23 | 09-01-2011 |
20120276102 | METHODS OF TREATMENT UTILIZIING BINDING PROTEINS OF THE INTERLEUKIN-21 RECEPTOR - The present invention provides binding proteins and antigen-binding fragments thereof, including human antibodies, that specifically bind to the human interleukin-21 receptor (IL-21R), and methods of using them. The binding proteins can act as, e.g., antagonists of IL-21R activity, thereby modulating immune responses in general, and those mediated by IL-21R in particular. The disclosed compositions and methods may be used, e.g., in diagnosing, treating, and/or preventing IL-21R-associated disorders, e.g., inflammatory disorders, autoimmune diseases, allergies, transplant rejection, and other immune system disorders. | 11-01-2012 |
20140286959 | Methods of Treating Inflammatory Disorders Using Anti-M-CSF Antibodies - The present invention relates to antibodies and antigen-binding portions thereof that specifically bind to a M-CSF, preferably human M-CSF, and that function to inhibit a M-CSF. The invention also relates to human anti-M-CSF antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-M-CSF antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-M-CSF antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-M-CSF antibodies. The invention also relates to transgenic animals and transgenic plants comprising nucleic acid molecules of the present invention. | 09-25-2014 |